3,901 results match your criteria JACC: Cardiovascular Interventions [Journal]


Minimizing Distal Embolization During Carotid Artery Stenting.

JACC Cardiovasc Interv 2019 Feb;12(4):404-405

Division of Cardiology, University Hospital, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.024DOI Listing
February 2019

Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon With Integrated Embolic Protection.

JACC Cardiovasc Interv 2019 Feb;12(4):395-403

Department of Angiology, Universitats Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Objectives: This study evaluated the safety and performance of the Paladin System, a novel angioplasty balloon with an integrated embolic protection filter designed to increase embolic protection during post-dilation.

Background: The risk of major adverse events during carotid artery stenting (CAS) is equivalent to carotid endarterectomy. However, the risk of minor stroke remains higher with CAS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.039DOI Listing
February 2019

Why a Threshold Case Volume in Complex Systems Such as Thrombectomy in Stroke Care Is Inadequate to Discriminate Quality Outcomes.

JACC Cardiovasc Interv 2019 Feb;12(4):392-394

Ochsner Clinical School, Ochsner Medical Center, New Orleans, Louisiana. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.002DOI Listing
February 2019

Higher Annual Operator Volume Is Associated With Better Reperfusion Rates in Stroke Patients Treated by Mechanical Thrombectomy: The ETIS Registry.

JACC Cardiovasc Interv 2019 Feb;12(4):385-391

Department of Neurology and Stroke Center, Centre Hospitalier de Versailles, Versailles, France; Versailles Saint-Quentin en Yvelines and Paris Saclay University, Versailles, France; INSERM LVTS (Laboratory for Vascular Translational Science)-1148, Paris, France. Electronic address:

Objectives: The aim of this study was to determine whether individual operator characteristics have an impact on reperfusion and procedural complication rates.

Background: Mechanical thrombectomy (MT) is a Level IA treatment in acute ischemic stroke (AIS) patients. The operator's effect has been found to be an independent predictor for clinical outcome and technical performance in interventional cardiology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.007DOI Listing
February 2019

Patterns of Left Ventricular Geometry and Clinical Outcome After Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2019 Feb;12(4):383-384

Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.021DOI Listing
February 2019

Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2019 Feb;12(4):373-382

Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts. Electronic address:

Objectives: The aim of this study was to evaluate the association between pre-procedural left ventricular hypertrophy (LVH) patterns and clinical outcomes after transcatheter aortic valve replacement (TAVR).

Background: The association between pre-procedural LVH pattern and severity and clinical outcomes after TAVR is uncertain.

Methods: Patients (n = 31,199) across 422 sites who underwent TAVR from November 2011 through June 2016 as part of the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapies) Registry linked with the Centers for Medicare and Medicaid Services database were evaluated by varying LVH patterns, according to sex-specific cutoffs for left ventricular mass index and relative wall thickness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.013DOI Listing
February 2019

The "Big Five" Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them?

JACC Cardiovasc Interv 2019 Feb;12(4):370-372

Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.019DOI Listing
February 2019

Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2019 Feb;12(4):362-369

Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.

Objectives: The aim of this study was to examine the independent association of short-term complications of transcatheter aortic valve replacement (TAVR) with survival and quality of life at 1 year.

Background: Prior studies have examined the mortality and cost implications of various complications of TAVR. However, many of these complications may primarily affect patients' quality of life after TAVR, which has not been previously studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.008DOI Listing
February 2019

Radial and Femoral Access for Revascularization of Coronary Chronic Total Occlusions: The Real Question Remains Unanswered.

JACC Cardiovasc Interv 2019 Feb;12(4):359-361

Cardiology Division, University of Texas Health Science Center, McGovern Medical School, Memorial Hermann Heart & Vascular Institute, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.015DOI Listing
February 2019

Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry.

JACC Cardiovasc Interv 2019 Feb;12(4):346-358

Minneapolis Heart Institute and the Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:

Objectives: This study examined the frequency and outcomes of radial access for chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

Background: Radial access improves the safety of PCI, but its role in CTO PCI remains controversial.

Methods: We compared the clinical, angiographic, and procedural characteristics of 3,790 CTO interventions performed between 2012 and 2018 via radial-only access (RA) (n = 747) radial-femoral access (RFA) (n = 844) and femoral-only access (n = 2,199) access at 23 centers in the United States, Europe, and Russia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.019DOI Listing
February 2019

The Circle of Life: Vieussens' Arterial Ring.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.016DOI Listing
February 2019

Percutaneous Device Closure of a Large Coronary Artery Fistula Post-Right Ventricular Endomyocardial Biopsy in a Pediatric Patient.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital, Saint Petersburg, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.008DOI Listing
February 2019

Facilitated Transfemoral Access by Shockwave Lithoplasty for Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Facultad de Medicina, Universidad de Salamanca, y CIBERCV, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.041DOI Listing
February 2019

"Rescue" LAMPOON to Treat Transcatheter Mitral Valve Replacement-Associated Left Ventricular Outflow Tract Obstruction.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Sussex Cardiac Centre, Royal Sussex County Hospital, Brighton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.026DOI Listing
February 2019

Management of Paravalvular Leak After Rapid Deployment Edwards Intuity Elite Valve.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Department of Interventional Cardiology, University of Rochester Medical Center, Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.023DOI Listing
February 2019

The Use of AngioVac Thrombectomy in IVC Filter-Associated Inferior Vena Cava Thrombosis.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.044DOI Listing
February 2019

Shockwave: Useful But Potentially Dangerous.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Interventional Cardiology Unit, University General Hospital of Ciudad Real, Ciudad Real, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.035DOI Listing
February 2019

Transcarotid Approach for Transcatheter Aortic Valve Replacement With the Sapien 3 Prosthesis: A Multicenter French Registry.

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Lille University Hospital, Lille, France. Electronic address:

Objectives: This study sought to describe the procedural and clinical outcomes of patients undergoing transcarotid (TC) transcatheter aortic valve replacement (TAVR) with the Edwards Sapien 3 device.

Background: The TC approach for TAVR holds the potential to become the optimal alternative to the transfemoral gold standard. Limited data exist regarding safety and efficacy of TC-TAVR using the Edwards Sapien 3 device. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.014DOI Listing
February 2019

Is Transcarotid an "Alternative" Access?

JACC Cardiovasc Interv 2019 Feb 7. Epub 2019 Feb 7.

Department of Cardiology, Houston Methodist Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.022DOI Listing
February 2019

One Size Does Not Fit All: Improving Recruitment and Retention of Women in Cardiovascular Device-Related Clinical Trials.

JACC Cardiovasc Interv 2019 Feb;12(3):309-311

Division of Cardiovascular Medicine, Stanford University, Stanford, California; Cardiovascular Research Institute, Stanford University, Stanford, California; Department of Medicine, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.012DOI Listing
February 2019

Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.

JACC Cardiovasc Interv 2019 Feb;12(3):301-308

Division of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut; BARTS Heart Center, St. Bartholomew's Hospital, and the William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. Electronic address:

Women have historically been underrepresented in clinical trials evaluating cardiovascular devices. Existing initiatives through government agencies have made some progress, but contemporary rates of female clinical trial participation leave much room for improvement. This position paper provides a narrative review and investigates reasons for the underrepresentation of women in cardiovascular trials. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.048DOI Listing
February 2019

Tipping Point: When Does Unilateral Branch Pulmonary Artery Stenosis Impede Exertional Performance?

JACC Cardiovasc Interv 2019 Feb;12(3):298-300

Division of Cardiology, Department of Pediatrics, Medical University of South Carolina, Congenital Heart Center, Charleston, South Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.027DOI Listing
February 2019

Balloon Angioplasty and Stenting for Unilateral Branch Pulmonary Artery Stenosis Improve Exertional Performance.

JACC Cardiovasc Interv 2019 Feb;12(3):289-297

Department of Pediatrics, UCSF Benioff Children's Hospital and the University of California, San Francisco, San Francisco, California.

Objectives: This study sought to determine whether pulmonary artery intervention in patients with unilateral proximal pulmonary artery stenosis (PAS) improves exercise capacity, abnormal ventilatory response to exercise, and symptoms.

Background: Stenosis of the branch pulmonary arteries results in pulmonary blood flow maldistribution (PBFM). The resulting ventilation-perfusion mismatch is associated with an increased ventilatory response to exercise and decreased exercise capacity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.042DOI Listing
February 2019

Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?

JACC Cardiovasc Interv 2019 Feb;12(3):285-288

Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, National Heart and Lung Institute, Royal Brompton Hospital, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.045DOI Listing
February 2019

Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.

JACC Cardiovasc Interv 2019 Feb 23;12(3):274-284. Epub 2018 Oct 23.

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address:

Objectives: The authors sought to assess the benefits of pulmonary artery denervation (PADN) among combined pre- and post-capillary pulmonary hypertension (CpcPH) patients in a prospective, randomized, sham-controlled trial.

Background: PADN has been shown to improve hemodynamics of pulmonary arterial hypertension in a series of patients. Additionally, benefits of targeted medical therapy for patients with CpcPH secondary to left-sided heart failure are unknown. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798183193
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2018.09.021DOI Listing
February 2019
7 Reads

Simultaneous Anatomic and Physiologic Assessment of Coronary Artery Disease With Coronary Angiography Alone: Seeing the Future.

JACC Cardiovasc Interv 2019 Feb;12(3):271-273

Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.032DOI Listing
February 2019

Next-Generation Bioresorbable Vascular Scaffolds: When to Get Our Hopes Up?

JACC Cardiovasc Interv 2019 Feb;12(3):256-258

Division of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.007DOI Listing
February 2019

Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months.

JACC Cardiovasc Interv 2019 Feb;12(3):245-255

Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China. Electronic address:

Objectives: The aim of this study was to investigate the operability, 6-month efficacy, and safety of the novel sirolimus-eluting iron bioresorbable coronary scaffold (IBS) system compared with a cobalt-chromium everolimus-eluting stent (EES) (XIENCE Prime stent) in porcine coronary arteries.

Background: Bioresorbable scaffolds have been considered the fourth revolution in percutaneous coronary intervention. However, the first-generation bioresorbable scaffold showed suboptimal results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.020DOI Listing
February 2019
7.345 Impact Factor

The Cost of Percutaneous Coronary Intervention for Chronic Total Occlusions in Our Current Cost-Conscious Environment.

JACC Cardiovasc Interv 2019 Feb 30;12(4):332-334. Epub 2019 Jan 30.

Department of Medicine (Cardiology Section), Carilion Clinic and Virginia Tech Carilion School of Medicine, Roanoke, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.051DOI Listing
February 2019

Protected Rotational Atherectomy With Double-Guiding Catheter Technique for Unprotected Distal Left Main.

JACC Cardiovasc Interv 2019 Feb 30;12(4):e27-e29. Epub 2019 Jan 30.

Interventional Cardiology Department, Istituto Clinico S. Ambrogio, Cardio-Thoracic Center, Gruppo San Donato, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.058DOI Listing
February 2019

Assessing the Likelihood of Chronic Total Occlusion Percutaneous Coronary Intervention Procedural Success: Not So Easy.

Authors:
Stephen G Ellis

JACC Cardiovasc Interv 2019 Feb 30;12(4):343-345. Epub 2019 Jan 30.

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.031DOI Listing
February 2019

"The Trapped Ventricle": Importance of Left Ventricular Unloading in Resuscitated Patients on VA-ECMO.

JACC Cardiovasc Interv 2019 Feb 30;12(4):e33-e34. Epub 2019 Jan 30.

Division of Cardiovascular Diseases and Cardiac Surgery, Robert Wood Johnson University Hospital, Rutgers University, New Brunswick, New Jersey. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.009DOI Listing
February 2019
1 Read
7.345 Impact Factor

Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score.

JACC Cardiovasc Interv 2019 Feb 30;12(4):335-342. Epub 2019 Jan 30.

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom. Electronic address:

Objectives: The aim was to establish a contemporary scoring system to predict the outcome of chronic total occlusion coronary angioplasty.

Background: Interventional treatment of chronic total coronary occlusions (CTOs) is a developing subspecialty. Predictors of technical success or failure have been derived from datasets of modest size. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.020DOI Listing
February 2019

Mechanical Circulatory Support With Impella Percutaneous Ventricular Assist Device as a Bridge to Recovery in Takotsubo Syndrome Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction.

JACC Cardiovasc Interv 2019 Feb 30;12(4):e31-e32. Epub 2019 Jan 30.

Intensive Cardiac Care Unit, Advanced Heart failure and Mechanical Circulatory Support Program, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.046DOI Listing
February 2019
1 Read

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.

JACC Cardiovasc Interv 2019 Feb 30;12(4):323-331. Epub 2019 Jan 30.

Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.

Objectives: The aim of this study was to describe the costs of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and the association of complications during CTO PCI with costs and length of stay (LOS).

Background: CTO PCI generally requires more procedural resources and carries higher risk for complications than PCI of non-CTO vessels. The costs of CTO PCI using the hybrid approach have not been described, and no studies have examined the impact of complications on in-hospital costs and LOS in this population. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798183213
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2018.10.025DOI Listing
February 2019
2 Reads

Coronary Chronic Total Occlusion With Collateral Channels From the Bronchial Artery.

JACC Cardiovasc Interv 2019 Feb 30;12(4):406-408. Epub 2019 Jan 30.

Toyohashi Heart Center, Toyohashi, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.030DOI Listing
February 2019

Patient Eligibility for Transcatheter Mitral Valve Replacement: A Small Piece of the Pie.

Authors:
David W M Muller

JACC Cardiovasc Interv 2019 Jan;12(2):205-207

St. Vincent's Hospital, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.025DOI Listing
January 2019

Causes and Clinical Outcomes of Patients Who Are Ineligible for Transcatheter Mitral Valve Replacement.

JACC Cardiovasc Interv 2019 Jan;12(2):196-204

Valve Science Center, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:

Objectives: The aim of this study was to gain insight into the causes and outcomes of patients who do not qualify for transcatheter mitral valve replacement (TMVR).

Background: Despite the increasing availability of TMVR, patients with severe mitral regurgitation may not be eligible. Thus far, no investigation has examined ineligible patients and their clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.042DOI Listing
January 2019
2 Reads

Predicting Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement: From Theory to Evidence.

JACC Cardiovasc Interv 2019 Jan;12(2):194-195

St. Paul's Hospital, University of British Colombia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.010DOI Listing
January 2019

Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement.

JACC Cardiovasc Interv 2019 Jan;12(2):182-193

Department of Interventional Cardiology, Cedars-Sinai Heart Institute, Los Angeles, California. Electronic address:

Objectives: The aim of this study was to evaluate the predictors of left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).

Background: LVOT obstruction is a major concern with TMVR, but limited data exist regarding its predictors and impact on outcomes.

Methods: Patients with pre-procedural multidetector row computed tomography (MDCT) undergoing TMVR for failed mitral bioprosthetic valves (valve-in-valve), annuloplasty rings (valve-in-ring), and mitral annular calcification (valve-in-MAC) were included in this study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.001DOI Listing
January 2019

The Tricuspid Valve: No Longer Forgotten But Still Misunderstood.

JACC Cardiovasc Interv 2019 Jan;12(2):179-181

University Heart Center, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.054DOI Listing
January 2019
1 Read

Right Atrioventricular Valve Leaflet Morphology Redefined: Implications for Transcatheter Repair Procedures.

JACC Cardiovasc Interv 2019 Jan;12(2):169-178

Visible Heart Laboratory, Departments of Biomedical Engineering and Surgery, University of Minnesota, Minneapolis, Minnesota; Institute for Engineering in Medicine, University of Minnesota, Minneapolis, Minnesota.

Objectives: The authors aimed to comprehensively detail the right atrioventricular valve functional leaflet anatomies.

Background: The rapid development of both surgical and percutaneous repair techniques for tricuspid regurgitation has renewed interest in variations in the morphology of the right atrioventricular valve.

Methods: The functioning right atrioventricular valves of 40 reanimated human hearts were imaged using Visible Heart methodologies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.029DOI Listing
January 2019
1 Read

From Color to Hemodynamic Assessment: Is it Time to Change the Paradigm in Judging MitraClip Outcomes?

JACC Cardiovasc Interv 2019 Jan;12(2):151-154

Cardiovascular Surgery Department, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.016DOI Listing
January 2019